GOLDMAN SACHS GROUP INC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 80 filers reported holding TG THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$14,136,342
-60.0%
1,690,950
+19.0%
0.00%
-57.1%
Q2 2023$35,306,831
+100.7%
1,421,370
+21.5%
0.01%
+75.0%
Q1 2023$17,589,310
+22.3%
1,169,502
-3.8%
0.00%
+33.3%
Q4 2022$14,380,087
+57.5%
1,215,561
-21.2%
0.00%
+50.0%
Q3 2022$9,128,000
+124.9%
1,541,921
+61.5%
0.00%
+100.0%
Q2 2022$4,058,000
-68.0%
954,679
-28.3%
0.00%
-66.7%
Q1 2022$12,671,000
-40.2%
1,332,402
+19.5%
0.00%
-25.0%
Q4 2021$21,186,000
-42.4%
1,115,066
+0.8%
0.00%
-50.0%
Q3 2021$36,804,000
+34.0%
1,105,875
+56.2%
0.01%
+33.3%
Q2 2021$27,462,000
-57.1%
707,981
-46.7%
0.01%
-62.5%
Q1 2021$64,076,000
+0.4%
1,329,380
+8.4%
0.02%0.0%
Q4 2020$63,798,000
+86.7%
1,226,427
-4.0%
0.02%
+60.0%
Q3 2020$34,173,000
+55.9%
1,277,025
+13.5%
0.01%
+42.9%
Q2 2020$21,923,000
+95.5%
1,125,399
-1.3%
0.01%
+75.0%
Q1 2020$11,216,000
-17.2%
1,139,875
-6.6%
0.00%
+33.3%
Q4 2019$13,548,000
+128.3%
1,220,522
+15.5%
0.00%
+50.0%
Q3 2019$5,934,000
-26.5%
1,056,753
+13.2%
0.00%0.0%
Q2 2019$8,075,000
+6.8%
933,502
-0.8%
0.00%0.0%
Q1 2019$7,562,000
+141.8%
940,656
+23.4%
0.00%
+100.0%
Q4 2018$3,127,000
+47.6%
762,585
+101.6%
0.00%0.0%
Q3 2018$2,119,000
-55.6%
378,311
+4.2%
0.00%0.0%
Q2 2018$4,776,000
-18.8%
363,181
-12.3%
0.00%0.0%
Q1 2018$5,880,000
+130.0%
414,128
+32.8%
0.00%0.0%
Q4 2017$2,557,000
+894.9%
311,793
+1335.0%
0.00%
Q3 2017$257,000
-48.7%
21,727
-49.5%
0.00%
Q1 2017$501,000
+534.2%
43,020
+152.8%
0.00%
Q4 2016$79,000
-11.2%
17,019
+48.8%
0.00%
Q3 2016$89,000
-87.5%
11,439
-73.4%
0.00%
Q2 2015$714,000
+80.3%
43,053
+68.5%
0.00%
Q1 2015$396,000
+308.2%
25,552
+148.5%
0.00%
Q2 2014$97,000
-86.6%
10,282
-90.9%
0.00%
Q2 2013$724,000113,2990.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 5,229,619$74,261,0003.55%
RA Capital Management 2,472,344$35,107,0002.69%
SENZAR ASSET MANAGEMENT, LLC 475,918$6,758,0002.13%
BRIDGER MANAGEMENT, LLC 2,373,920$33,710,0002.04%
Opaleye Management Inc. 274,200$3,893,0001.11%
Virtus ETF Advisers LLC 89,920$1,277,0001.11%
Eversept Partners, LP 150,000$2,130,0000.99%
Ghost Tree Capital, LLC 300,000$4,260,0000.86%
PURA VIDA INVESTMENTS, LLC 50,000$710,0000.42%
HIGHLAND CAPITAL MANAGEMENT LP 464,391$6,595,0000.34%
View complete list of TG THERAPEUTICS INC shareholders